GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 676 - 700 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G14844CX
354
IgG Patient 2 3 mild
G14844CX
46
IgM Patient 2 3 mild
G14844CX
169
IgA Patient 3 -180 mild
G14844CX
265
IgA Patient 3 11 mild
G14844CX
362
IgG Patient 3 -180 mild
G14844CX
53
IgG Patient 3 11 mild
G14844CX
45
IgM Patient 3 -180 mild
G14844CX
91
IgA Patient 3 4 mild
G14844CX
374
IgG Patient 3 4 mild
G14844CX
42
IgM Patient 3 11 mild
G14844CX
104
IgM Patient 3 4 mild
G14844CX
94
IgA Patient 4 12 mild
G14844CX
1193
IgG Patient 4 12 mild
G14844CX
295
IgM Patient 4 12 mild
G14844CX
2240
IgA Patient 1 10 moderate
G14988WV
410
IgA Patient 1 22 moderate
G14988WV
450
IgA Patient 1 6 moderate
G14988WV
290
IgG Patient 1 10 moderate
G14988WV
34
IgG Patient 1 22 moderate
G14988WV
49
IgG Patient 1 6 moderate
G14988WV
25
IgM Patient 1 10 moderate
G14988WV
69
IgM Patient 1 22 moderate
G14988WV
220
IgM Patient 1 6 moderate
G14988WV
42
IgA Patient 2 15 mild
G14988WV
380

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024